and I noticed a significant weight drop
Honigberg, M

CrossRef Hepatic inflammation after exposure to a mixture of low-dose arsenic and cadmium in a murine model of fatty liver disease Nivetha K Subramaniam, Natascha Gagnon, Cynthia Guilbert, Rushmi Perinpanathan, Madelyn Abraham, Christophe Goncalves, Jaymie R Meliker, Sonia Del Rincon, Koren K Mann Toxicological Sciences .2026;[Epub] CrossRef Human placenta extract declines fat deposition in an in vitro novel 3D MASLD model Parisa Taheri, Fatemeh Majidi, Kosar Nouri, Masoumeh Nouri, Morteza Zarrabi, Elham Rismani, Abbas Piryaei, Massoud Vosough In vitro models .2026;[Epub] CrossRef DNMT1 facilitates the progression of metabolic dysfunction-associated steatotic liver disease by impeding transcription mediated by HNF4 and PPAR Hyun Ahm Sohn, Hanyong Go, Tae Hyeon An, Jun Min Lee, Hee-Jin Kim, Keeok Haam, Amal Magdy, Hyo-Jung Jung, Yang-Ji Shin, Hyun Jung Lim, Yujin Jeong, Yejin Bae, Youngae Jung, Seong-Hwan Park, Kyung Chan Park, Myeong Jun Song, Eun-Wie Cho, Eun-Soo Kwon, Jeon Clinical and Molecular Hepatology .2026

Increasing glutathione lowers free-radical damage in the lungs, which reduced the likelihood of developing COPD
How to code it: Primary code: K59.09 (Other constipation), to capture the acute exacerbation that is the reason for the current encounter Secondary code: K59.04 (Chronic idiopathic constipation) or K59.01 (slow transit if confirmed by prior testing), to capture the underlying chronic condition Coder tip: Do not code K59.04 + K59.09 for the same encounter without clear documentation that both the chronic baseline and the acute exacerbation are being addressed
Short Description A telehealth platform offering physician-supervised semaglutide treatment with personalized care and continued medical support